Skip to content

Clinical trials

Completed Metabolic Diseases trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Metabolic Diseases Status: Completed Country / region: Taiwan Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20094
20111
20171
20181
20201
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company3
Kastle Therapeutics, LLC2
Regeneron Pharmaceuticals2
Chang Gung Memorial Hospital1
Ionis Pharmaceuticals, Inc.1
Panion & BF Biotech Inc.1
Takeda1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Metabolic Diseases11
Diabetes Mellitus, Type 24
Genetic Diseases, Inborn4
Metabolism, Inborn Errors4
Diabetes Mellitus3
Glucose Metabolism Disorders3
Hyperlipidemias3
Arthritis2
Congenital Abnormalities2
Dyslipidemias2

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.